Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David A Fishman

Showing results (41-50 of 57) with videos related to

Pageof 6
Sort By:
Journal of Ultrasound in Medicine : Official Journal of the American Institute of Ultrasound in Medicine|September 26, 2009
Diagnostic parameters to differentiate benign from malignant ovarian masses with contrast-enhanced transvaginal sonographyArthur C Fleischer, Andrej Lyshchik, Howard W Jones, et al.
Proteomics|November 5, 2003
Signal pathway profiling of ovarian cancer from human tissue specimens using reverse-phase protein microarraysJulia D Wulfkuhle, Joy A Aquino, Valerie S Calvert, et al.
Molecular Cancer Research : MCR|February 23, 2007
Lysophosphatidic acid down-regulates stress fibers and up-regulates pro-matrix metalloproteinase-2 activation in ovarian cancer cellsThuy-Vy Do, Jay C Symowicz, David M Berman, et al.
Journal of Ultrasound in Medicine : Official Journal of the American Institute of Ultrasound in Medicine|June 26, 2008
Contrast-enhanced transvaginal sonography of benign versus malignant ovarian masses: preliminary findingsArthur C Fleischer, Andrej Lyshchik, Howard W Jones, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 1, 2005
Soluble epidermal growth factor receptor (sEGFR) [corrected] and cancer antigen 125 (CA125) as screening and diagnostic tests for epithelial ovarian cancerAndre T Baron, Cecelia H Boardman, Jacqueline M Lafky, et al.
American Journal of Obstetrics and Gynecology|April 23, 2005
The role of ultrasound evaluation in the detection of early-stage epithelial ovarian cancerDavid A Fishman, Leeber Cohen, Stephanie V Blank, et al.
Cancer Research|June 19, 2008
Matrix metalloproteinase 9 is a mediator of epidermal growth factor-dependent e-cadherin loss in ovarian carcinoma cellsKaren D Cowden Dahl, Jaime Symowicz, Yan Ning, et al.
Cancer Research|March 3, 2007
Engagement of collagen-binding integrins promotes matrix metalloproteinase-9-dependent E-cadherin ectodomain shedding in ovarian carcinoma cellsJaime Symowicz, Brian P Adley, Kara J Gleason, et al.
Gynecologic Oncology|January 9, 2010
Lysophosphatidic acid (LPA) effects on endometrial carcinoma in vitro proliferation, invasion, and matrix metalloproteinase activityFeng-qiang Wang, Edgardo V Ariztia, Leslie R Boyd, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 14, 2002
Methylation profiles of sporadic ovarian tumors and nonmalignant ovaries from high-risk womenAsha Rathi, Arvind K Virmani, John O Schorge, et al.
Pageof 6

Showing results (41-50 of 57) with videos related to

Sort By:
Pageof 6
Journal of Ultrasound in Medicine : Official Journal of the American Institute of Ultrasound in Medicine|September 26, 2009
Diagnostic parameters to differentiate benign from malignant ovarian masses with contrast-enhanced transvaginal sonographyArthur C Fleischer, Andrej Lyshchik, Howard W Jones, et al.
Proteomics|November 5, 2003
Signal pathway profiling of ovarian cancer from human tissue specimens using reverse-phase protein microarraysJulia D Wulfkuhle, Joy A Aquino, Valerie S Calvert, et al.
Molecular Cancer Research : MCR|February 23, 2007
Lysophosphatidic acid down-regulates stress fibers and up-regulates pro-matrix metalloproteinase-2 activation in ovarian cancer cellsThuy-Vy Do, Jay C Symowicz, David M Berman, et al.
Journal of Ultrasound in Medicine : Official Journal of the American Institute of Ultrasound in Medicine|June 26, 2008
Contrast-enhanced transvaginal sonography of benign versus malignant ovarian masses: preliminary findingsArthur C Fleischer, Andrej Lyshchik, Howard W Jones, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 1, 2005
Soluble epidermal growth factor receptor (sEGFR) [corrected] and cancer antigen 125 (CA125) as screening and diagnostic tests for epithelial ovarian cancerAndre T Baron, Cecelia H Boardman, Jacqueline M Lafky, et al.
American Journal of Obstetrics and Gynecology|April 23, 2005
The role of ultrasound evaluation in the detection of early-stage epithelial ovarian cancerDavid A Fishman, Leeber Cohen, Stephanie V Blank, et al.
Cancer Research|June 19, 2008
Matrix metalloproteinase 9 is a mediator of epidermal growth factor-dependent e-cadherin loss in ovarian carcinoma cellsKaren D Cowden Dahl, Jaime Symowicz, Yan Ning, et al.
Cancer Research|March 3, 2007
Engagement of collagen-binding integrins promotes matrix metalloproteinase-9-dependent E-cadherin ectodomain shedding in ovarian carcinoma cellsJaime Symowicz, Brian P Adley, Kara J Gleason, et al.
Gynecologic Oncology|January 9, 2010
Lysophosphatidic acid (LPA) effects on endometrial carcinoma in vitro proliferation, invasion, and matrix metalloproteinase activityFeng-qiang Wang, Edgardo V Ariztia, Leslie R Boyd, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 14, 2002
Methylation profiles of sporadic ovarian tumors and nonmalignant ovaries from high-risk womenAsha Rathi, Arvind K Virmani, John O Schorge, et al.
Pageof 6